Legend Biotech Corporation
LEGN
$22.32
-$0.69-3.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -18.13% | -25.10% | -22.80% | -14.21% | -14.85% |
| Total Receivables | 94.82% | 125.89% | 114.03% | -20.48% | 109.27% |
| Inventory | 23.93% | 88.60% | 39.68% | 23.00% | 30.72% |
| Prepaid Expenses | 84.65% | 43.44% | 42.07% | 1.17% | -43.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -87.99% | -83.76% | -80.50% | -80.39% | 63.76% |
| Total Current Assets | -8.00% | -12.28% | -13.79% | -14.28% | -10.52% |
|
|
|||||
| Total Current Assets | -8.00% | -12.28% | -13.79% | -14.28% | -10.52% |
| Net Property, Plant & Equipment | 24.70% | 6.31% | 11.10% | 6.34% | 10.40% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -22.91% | -33.95% | -46.81% | -37.47% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 23.91% | 39.51% | 12.13% | 16.54% | 27.07% |
| Total Assets | -1.32% | -6.02% | -8.98% | -9.65% | -5.63% |
|
|
|||||
| Total Accounts Payable | 280.79% | 90.84% | 47.25% | 25.90% | 56.68% |
| Total Accrued Expenses | -- | -- | -47.67% | 4.76% | 21.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3,360.32% | 77.62% | 71.41% | 50.99% | 48.95% |
| Total Finance Division Other Current Liabilities | 83.76% | 54.82% | 17.07% | 40.28% | 155.01% |
| Total Other Current Liabilities | 83.76% | 54.82% | 17.07% | 40.28% | 155.01% |
| Total Current Liabilities | 60.05% | -9.79% | -6.13% | 28.29% | 54.60% |
|
|
|||||
| Total Current Liabilities | 60.05% | -9.79% | -6.13% | 28.29% | 54.60% |
| Long-Term Debt | -42.04% | 6.42% | 6.76% | 7.06% | 7.51% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 93.01% | 62.89% | 14.50% | 1.01% | 9.45% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 23.57% | -25.77% | -79.67% | -88.88% | -4.47% |
| Total Liabilities | 13.23% | 2.38% | -2.15% | 5.42% | 24.02% |
|
|
|||||
| Common Stock & APIC | 1.96% | 2.21% | 2.53% | 2.23% | 1.97% |
| Retained Earnings | -14.20% | -20.82% | -14.12% | -11.92% | -25.98% |
| Treasury Stock & Other | 69.50% | 307.20% | 7.76% | -93.66% | 159.69% |
| Total Common Equity | -9.39% | -10.65% | -12.57% | -16.85% | -16.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.39% | -10.65% | -12.57% | -16.85% | -16.69% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.39% | -10.65% | -12.57% | -16.85% | -16.69% |
|
|
|||||